{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:51:20Z","timestamp":1791327080426,"version":"4.3.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RF1AG094856"],"award-info":[{"award-number":["1RF1AG094856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tips.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:17:15Z","timestamp":1790857035000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterochiral peptides reshaping class B1 GPCR agonism"],"prefix":"10.1016","author":[{"given":"Heng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-3306","authenticated-orcid":false,"given":"Jianfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.09.003_bb0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s43586-026-00503-5","article-title":"Peptide ligand discovery of G protein-coupled receptors","volume":"6","author":"Hermes","year":"2026","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.tips.2026.09.003_bb0010","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s12276-025-01497-y","article-title":"Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tips.2026.09.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407574122","article-title":"Prolonged signaling of backbone-modified glucagon-like peptide-1 analogues with diverse receptor trafficking","volume":"122","author":"Cary","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.09.003_bb0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/acschembio.2c00175","article-title":"Design of potent and proteolytically stable biaryl-stapled GLP-1R\/GIPR peptide dual agonists","volume":"17","author":"Yang","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2026.09.003_bb0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41557-026-02182-x","article-title":"Potent and biased agonists of class B1 GPCRs from a heterochiral design strategy","volume":"18","author":"Gibadullin","year":"2026","journal-title":"Nat. Chem."},{"key":"10.1016\/j.tips.2026.09.003_bb0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1021\/acsinfecdis.3c00491","article-title":"Mechanism of protease resistance of D-amino acid residue containing cationic antimicrobial heptapeptides","volume":"10","author":"Sarkar","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tips.2026.09.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217604120","article-title":"Endogenous L- to D-amino acid residue isomerization modulates selectivity between distinct neuropeptide receptor family members","volume":"120","author":"Yussif","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.09.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110466","article-title":"Insights into the structural dynamics of the secretin family (class B1) G protein-coupled receptors","volume":"301","author":"Liu","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.09.003_bb0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41589-021-00945-w","article-title":"Structural and functional diversity among agonist-bound states of the GLP-1 receptor","volume":"18","author":"Cary","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2026.09.003_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coph.2016.07.004","article-title":"Impact, determination and prediction of drug-receptor residence times for GPCRs","volume":"30","author":"Tautermann","year":"2016","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:22:31Z","timestamp":1791325351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726002324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"alternative-id":["S0165614726002324"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.09.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterochiral peptides reshaping class B1 GPCR agonism","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}